Quick Takeaways
- N. Anthony Coles has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,322,985.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of N. Anthony Coles
- Location
- Tarrytown, NY
- Summary
- The estimated net worth of N. Anthony Coles is at least $1,322,985 dollars as of 06 Jan 2026. N. Anthony Coles is the Director of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $1.32M.
- Signature
- By: Richard Gluckselig as attorney-in-fact For: N. Anthony Coles
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow N. Anthony Coles and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: REGENERON PHARMACEUTICALS, INC. ($1,322,985).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of N. Anthony Coles
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | Director | $1,322,985 | 02 Jan 2026 | ||
| CERE | Cerevel Therapeutics Holdings, Inc. | Director | $0 | 01 Aug 2024 |
Insider Transactions Reported by N. Anthony Coles:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.